Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 5Anxiety Disorders 2Pain, Postoperative 1Neoplasm Regression, Spontaneous 1Fatigue 1Carcinoma, Intraductal, Noninfiltrating 1Breast Cancer Female 1

Interventions

Bupivacaine 8Control Groups 6Saline Solution 5Ropivacaine 5Ketamine 5Sodium Chloride 4Lidocaine 4Dexmedetomidine 4Anesthetics, Local 4Morphine 3Anti-Inflammatory Agents, Non-Steroidal 3Diazepam 2Botulinum Toxins, Type A 2Analgesics, Opioid 2Acetaminophen 2thiamine triphosphorate 1oxycodone-acetaminophen 1esmolol 1Vitamins 1Tramadol 1Therapeutics 1Surgical Procedures, Operative 1Sufentanil 1Nerve Block 1Narcotics 1Nalbuphine 1Mindfulness 1Mastectomy, Segmental 1Mammaplasty 1Magnesium Sulfate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pain, Postoperative × Acceptance and Commitment Therapy × Breast × Clear all
NCT03430765 2019-02-11

Preventing Persistent Pain and Reducing Depressive and Anxious Symptoms Following Mastectomy and Lumpectomy

University of Iowa

Phase NA Completed
62 enrolled
Breast

Carcinoma, Intraductal, Noninfiltrating, Pain, Postoperative

Data powered by HemOnc (CC BY 4.0) Colophon âš¡